Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

101760

registered interest
date	30/10/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Biotechnology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what steps his Department is taking to promote the UK as a location of choice for life science investment in trade missions.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212638
answer	answer is ministerial correction date of answer 07/11/2014 answer text <p>The Life Sciences Organisation (LSO), sitting within UK Trade and Investment (UKTI), is responsible for promoting the UK as an investment destination for life sciences, as well as supporting UK companies to increase exports to other markets. The team comprises a mixture of industry specialists and experienced civil servants, who together provide a range of support to potential investors and exporters.</p><p> </p><p>The LSO has developed a suite of marketing materials that showcase the UK’s life sciences capabilities across a number of priority sub-sectors, including but not limited to pharmaceutical manufacturing, regenerative medicine and experimental medicine &amp; clinical trials. Within each theme the LSO promotes the UK through direct, in-market company visits and/or tailored events and activities around the world, and works with international companies that would be well placed to take advantage of the UK offer. In 2013/14, the Life Sciences Organisation delivered 136 FDI projects creating or safeguarding more than 3,500 jobs.</p><p> </p> answering member constituency West Suffolk answering member printed Matthew Hancock question first answered 07/11/2014 14:43:43 answering member 4070 label Biography information for Matt Hancock
tabling member	4051 label Biography information for John Glen

101761

registered interest
date	30/10/2014
answering body	Department for Business, Innovation and Skills
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Biotechnology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Innovation and Skills, what estimate he has made of the number of jobs in each region and constituent part of the UK which are supported by the life science industry.
tabling member constituency	Salisbury
tabling member printed	John Glen
uin	212639
answer	answer is ministerial correction date of answer 07/11/2014 answer text <p>There are no published official statistics on the regional distribution of life science industry jobs. The table below includes an estimate of employment in 2013 in companies active in three “health life science” sectors: Medical Biotechnology, Medical Technology and Pharmaceuticals, by region and by constituent part of the UK, obtained from the Bioscience and Health Technology company database used by the Office for Life Sciences. The figures are based on locations of active sites for which employment figures can be obtained. They do not include those employed by public or third sector organisations nor employment in companies whose main activity falls outside life sciences, including indirect suppliers to the sector.</p><p> </p><table><tbody><tr><td> </td><td><p><strong>Number of employees in health life science industry ‘000s 2013</strong></p></td></tr><tr><td><p>East Midlands</p></td><td><p>9.5</p></td></tr><tr><td><p>East of England</p></td><td><p>28.8</p></td></tr><tr><td><p>Greater London</p></td><td><p>13.6</p></td></tr><tr><td><p>North East England</p></td><td><p>7.1</p></td></tr><tr><td><p>North West England</p></td><td><p>17.0</p></td></tr><tr><td><p>South East England</p></td><td><p>36.8</p></td></tr><tr><td><p>South West England</p></td><td><p>8.2</p></td></tr><tr><td><p>West Midlands</p></td><td><p>14.5</p></td></tr><tr><td><p>Yorkshire and the Humber</p></td><td><p>13.5</p></td></tr><tr><td><p>England total</p></td><td><p>149.0</p></td></tr><tr><td> </td><td> </td></tr><tr><td><p>Northern Ireland</p></td><td><p>4.3</p></td></tr><tr><td><p>Scotland</p></td><td><p>11.5</p></td></tr><tr><td><p>Wales</p></td><td><p>9.1</p></td></tr><tr><td><p>UK Total</p></td><td><p>173.9</p></td></tr></tbody></table><p>Source: Bioscience and Health Technology database, an annual summary of the data was published as “Strength and Opportunity 2013, the landscape of the medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors in the UK”</p><p> </p><p> </p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 07/11/2014 16:53:00 answering member 4020 label Biography information for George Freeman
tabling member	4051 label Biography information for John Glen